CIBC World Market
EPRX

CIBC World Market’s Eupraxia Pharmaceuticals EPRX Stock Holding History

CIBC World Market’s Portfolio EPRX Stock Details EPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.54M Buy
234,673
+83,723
+55% +$577K ﹤0.01% 920
2026
Q1 		$1.09M Buy
150,950
+92,900
+160% +$748K ﹤0.01% 909
2025
Q4 		$437K Buy
58,050
+43,050
+287% +$265K ﹤0.01% 1164
2025
Q3 		$88.4K Hold
15,000
– – ﹤0.01% 1377
2025
Q2 		$86.4K Buy
+15,000
New +$57.6K ﹤0.01% 1321

Other funds holding EPRX

BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $13.6B AUM 17.82% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $26.8B AUM 33.07% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

CIBC World Market's EPRX Position: Q2 2026 in Review

CIBC World Market increased its Eupraxia Pharmaceuticals (EPRX) stake by 55% in Q2 2026, buying an estimated $577K and bringing the position to 234,673 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #920.

CIBC World Market first reported a position in EPRX in Q2 2025 and has held it in 5 quarters since. 67 funds tracked by Wall St. Rank hold EPRX as of Q2 2026.

  • CIBC World Market held 234,673 shares of Eupraxia Pharmaceuticals worth $1.54M as of Q2 2026.
  • CIBC World Market bought 83,723 Eupraxia Pharmaceuticals shares in Q2 2026, an estimated $577K.
  • Eupraxia Pharmaceuticals made up ﹤0.01% of CIBC World Market's portfolio in Q2 2026, its #920 holding.
  • CIBC World Market first reported a position in Eupraxia Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 67 funds tracked by Wall St. Rank held Eupraxia Pharmaceuticals as of Q2 2026.

Based on CIBC World Market's 13F filing for Q2 2026, filed 13 Aug 2026.